Yes I recall quite a few on the boards over there patting him on...

Yes I recall quite a few on the boards over there patting him on the back on his decision to sell half his OCC holding and join that pharma coy back in Feb 2022. One proclaiming it will perform, "much better than OCC," while another said, "half-exited from the OCCult world of stem cells to become an IMUgenie!"

In that time the SP has gone from 32c down to 10c. Painful.

These companies always take longer to advance than people realise and while its been stated many a time on here that Orthocell has taken far too long, but we're finally on the cusp of gaining serious appreciation through actual growth of sales. To paraphrase PA, it really is an exciting time for the company.

Obviously, I think we need to see the SP come off a little, stabilise and consolidate and retest the 200Day MA again. Perhaps when ATI results are released we'll see some selling into the news which would present another opportunity to top up. And If that happens, prepare for the usual suspects to moan and groan about it.